Squarepoint
ALNA

Squarepoint’s Allena Pharmaceuticals ALNA Stock Holding History

Squarepoint’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,840
Closed -$23K – 3806
2020
Q4 		$23K Buy
+17,840
New +$24.9K ﹤0.01% 2834
2020
Q3 		– Sell
-51,524
Closed -$81K – 2968
2020
Q2 		$81K Buy
+51,524
New +$86.5K ﹤0.01% 2046
2019
Q2 		– Sell
-40,400
Closed -$284K – 2759
2019
Q1 		$284K Sell
40,400
-3,100
-7% -$22.5K ﹤0.01% 1799
2018
Q4 		$237K Buy
43,500
+1,600
+4% +$13.8K ﹤0.01% 1612
2018
Q3 		$450K Buy
41,900
+22,589
+117% +$248K 0.01% 1352
2018
Q2 		$252K Buy
+19,311
New +$278K ﹤0.01% 1455

Other funds holding ALNA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Squarepoint's ALNA Position: Q1 2021 in Review

Squarepoint sold out of Allena Pharmaceuticals (ALNA) in Q1 2021, closing a stake of 17,840 shares — an estimated $23K sold.

Squarepoint first reported a position in ALNA in Q2 2018 and held it in 6 quarters. The position peaked at $450K in Q3 2018. 30 funds tracked by Wall St. Rank hold ALNA as of Q1 2021.

  • Squarepoint reported no remaining Allena Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Squarepoint sold 17,840 Allena Pharmaceuticals shares in Q1 2021, an estimated $23K.
  • Squarepoint first reported a position in Allena Pharmaceuticals in Q2 2018 and held it in 6 quarters.
  • Squarepoint's Allena Pharmaceuticals position peaked at $450K in Q3 2018.
  • 30 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2021.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.